Floatz logo

cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes

B Acute Lymphoblastic Leukemia

City of Hope Medical CenterCell therapyPhase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

140 Active assets in the B Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
University of Washington
Phase 3BBB
VINCRISTINE SULFATE
City of Hope Medical Center
Phase 3BB
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
City of Hope Medical Center
Phase 3BB
MERCAPTOPURINE ANHYDROUS
SWOG Cancer Research Network
Phase 3BB
PEGASPARGASE
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes is also rated in:

mantle cell lymphomaDormant
CCC
Indicative ·
53 / 100
View asset →
acute lymphoblastic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
primary central nervous system lymphomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →